News from <i>Endocrine-Related Cancer</i> (2)

Endocrine-Related Cancer is the premier, global journal publishing basic, translational and clinical research on hormones and cancer with an impressive impact factor of 5.236. All reviews are published free online at www.try-erc.org

The March issue featured a review section on MicroRNAs, read the editorial by Alfredo Fusco at http://erc.endocrinology-journals.org/cgi/content/full/17/1/E3.

Take a look at some of the most popular recently published articles:

Cistromics of hormone-dependent cancer. Mathieu Lupien and Myles Brown (read here).

MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Rosa Visone et al. (read here).

Adiponectin signals in prostate cancer cells through Akt to activate the mammalian target of rapamycin pathway. D Barb, A Neuwirth, C S Mantzoros, S P Balk (read here).

Come and see Endocrine-Related Cancer at the European Congress of Endocrinology 2010, 24-27 April in Prague at the Prague Convention Centre: www.ece2010.com. We will be offering free trials of ERC to anyone who comes along to our booth number 20 during the conference.